Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
So with 60 lots at an average of 2,000 liters each, that would be 120,000 to 180,000 treatments this year. Next year with 80 lots, it'd be 160,000 to 240,000 treatments.
If lenz gets an EUA, how high could production get realistically do you think?
Do you know how CytoDyn survived between 2008 and 2012? What was the product they were pumping before they bought the rights to PRO-140/leronlimab? It is hard to imagine Nader being successful at getting people to invest in a company coming out of bankruptcy. My guess is that there is some super sketchy story behind it. We know Nader never attempts anything the honorable way.
This confirms lenz's MoA in CAR-T. They could be another potential partner for lenz.
So is the picture of the 10mL bottle that we keep seeing the actual dose that has 1,800mg of lenz? Or maybe it is 600mg since there are 3 treatment sessions?
I'm trying to use his numbers to calculate how many doses are being made. 60 lots with most being 2,000 liters or 2,100 liters (a few as small as 100 liters and some as big as 4,000 liters).